• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化良好的乳头状间皮瘤:一个新的名称和新的问题。

Well differentiated papillary mesothelial tumor: a new name and new problems.

机构信息

Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada.

MESOPATH College, MESONAT, MESOBANK, Department of BioPathology Centre Léon Bérard, and INSERM 1052, CNRS 5286 of Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France.

出版信息

Mod Pathol. 2022 Oct;35(10):1327-1333. doi: 10.1038/s41379-022-01082-y. Epub 2022 Apr 19.

DOI:10.1038/s41379-022-01082-y
PMID:35440764
Abstract

Well-differentiated papillary mesothelial tumor (WDPMT, formerly called well-differentiated papillary mesothelioma) is a morphologically distinctive lesion composed of expansile papillae with a myxoid core covered by a single layer of generally bland mesothelial cells. Whether some WDPMT are precursors of invasive mesothelioma is uncertain, and this question is confounded by shallow biopsies of ordinary diffuse mesotheliomas that have superficial areas resembling WDPMT as well as by misinterpretation of some cases of mesothelioma in situ. Genetic analyses on a very small number of published cases of peritoneal WDPMT have shown a variety of mutations/copy number losses that do not overlap at all with those that are found recurrently in invasive mesotheliomas. The newly described entity of mesothelioma in situ usually appears as a single layer of mesothelial cells that have lost BAP1 by immunostaining, but sometimes is papillary and produces a morphologic mimic of WDPMT. We propose that, at least in the peritoneal cavity where most WDPMT occur, there are two morphologically identical but functionally distinct lesions: one is true WDPMT, a process that is probably benign, and the other is papillary mesothelioma in situ with the configuration of WDPMT. For that reason immunostaining for BAP1, and if necessary MTAP or CDKN2A FISH, should always be performed on cases with the appearance of WDPMT. It is possible, but speculative, that the small number of reports in the literature which describe invasive mesothelioma arising from WDMPT are actually describing invasive mesothelioma arising from mesothelioma in situ that looks like WDPMT.

摘要

分化良好的乳头状间皮瘤(WDPMT,以前称为分化良好的乳头状间皮瘤)是一种形态独特的病变,由扩张的乳头组成,乳头中心为黏液样物质,被单层通常为温和的间皮细胞覆盖。一些 WDPMT 是否是侵袭性间皮瘤的前体尚不确定,这个问题因普通弥漫性间皮瘤的浅层活检而变得复杂,这些活检有类似于 WDPMT 的浅表区域,以及一些原位间皮瘤的错误解释。对少数已发表的腹膜 WDPMT 的遗传分析表明,各种突变/拷贝数丢失与侵袭性间皮瘤中经常发现的突变/拷贝数丢失完全不重叠。新描述的原位间皮瘤实体通常表现为单层间皮细胞,通过免疫染色失去了 BAP1,但有时呈乳头状,产生类似于 WDPMT 的形态模拟。我们提出,至少在腹膜腔中,大多数 WDPMT 发生的部位,存在两种形态相同但功能不同的病变:一种是真正的 WDPMT,这是一个可能良性的过程,另一种是具有 WDPMT 形态的乳头状原位间皮瘤。因此,对于具有 WDPMT 外观的病例,应始终进行 BAP1 的免疫染色,如果必要,还应进行 MTAP 或 CDKN2A FISH。文献中有少数几篇报道描述了从 WDMPT 中发生的侵袭性间皮瘤,这些报道实际上可能描述的是从看起来像 WDPMT 的原位间皮瘤中发生的侵袭性间皮瘤。

相似文献

1
Well differentiated papillary mesothelial tumor: a new name and new problems.分化良好的乳头状间皮瘤:一个新的名称和新的问题。
Mod Pathol. 2022 Oct;35(10):1327-1333. doi: 10.1038/s41379-022-01082-y. Epub 2022 Apr 19.
2
The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature.BAP1 和 MTAP/CDKN2A 表达在分化良好的乳头状间皮瘤中的意义:21 例系列病例及文献复习。
Pathology. 2024 Aug;56(5):662-670. doi: 10.1016/j.pathol.2024.02.016. Epub 2024 May 9.
3
New developments in mesothelial pathology.间皮病理学的新进展
Histopathology. 2024 Jan;84(1):136-152. doi: 10.1111/his.15007. Epub 2023 Sep 11.
4
Mesothelioma In Situ Mimicking Well-differentiated Papillary Mesothelial Tumor.原位间皮瘤模拟分化良好的乳头状间皮瘤。
Am J Surg Pathol. 2023 May 1;47(5):611-617. doi: 10.1097/PAS.0000000000002033. Epub 2023 Mar 6.
5
Mesothelioma of Uncertain Malignant Potential (MUMP) of the Tunica Vaginalis: Proposal for Reclassification as "Complex Mesothelial Tumor of the Tunica Vaginalis".不确定恶性潜能的鞘膜间皮瘤(MUMP):建议重新分类为“鞘膜复杂间皮瘤”。
Am J Surg Pathol. 2024 Apr 1;48(4):387-394. doi: 10.1097/PAS.0000000000002185. Epub 2024 Jan 25.
6
Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years.腹膜原位乳头状间皮瘤:BAP1 突变,15 年来表现为惰性行为。
Virchows Arch. 2023 Dec;483(6):873-878. doi: 10.1007/s00428-023-03593-8. Epub 2023 Jul 10.
7
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature.腹膜间皮瘤原位:三例报告及文献复习。
Histopathology. 2024 Feb;84(3):492-506. doi: 10.1111/his.15092. Epub 2023 Dec 12.
8
Mesothelioma: morphologic and immunohistochemical findings.间皮瘤:形态学及免疫组化结果
Pathologie (Heidelb). 2024 Sep;45(5):309-315. doi: 10.1007/s00292-024-01317-6. Epub 2024 Apr 3.
9
Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors.分化良好型腹膜间皮乳头状肿瘤患者的临床特征和转归。
Ann Surg Oncol. 2024 Nov;31(12):7973-7977. doi: 10.1245/s10434-024-16004-2. Epub 2024 Aug 21.
10
Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.恶性腹膜间皮瘤的基因组分析揭示了表观遗传调控基因BAP1、SETD2和DDX3X的复发性改变。
Mod Pathol. 2017 Feb;30(2):246-254. doi: 10.1038/modpathol.2016.188. Epub 2016 Nov 4.

引用本文的文献

1
A diagnostic challenge of primary serous borderline tumor involving the peritoneum: A case report.原发性浆液性交界性肿瘤累及腹膜的诊断挑战:一例报告
Int J Surg Case Rep. 2025 Aug;133:111527. doi: 10.1016/j.ijscr.2025.111527. Epub 2025 Jun 16.
2
Consensus Guideline for the Management of Peritoneal Mesothelioma.腹膜间皮瘤管理共识指南
Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17358-x.
3
Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma.胸膜间皮瘤病理诊断方法中的挑战
Cancers (Basel). 2025 Feb 1;17(3):481. doi: 10.3390/cancers17030481.
4
Case report: Imaging of adrenal adenomatoid tumors: reports of two cases and review of literature.病例报告:肾上腺腺瘤样瘤的影像学表现:两例报告并文献复习
Front Oncol. 2024 Oct 4;14:1435143. doi: 10.3389/fonc.2024.1435143. eCollection 2024.
5
Clinical Characteristics and Outcomes of Patients with Well-Differentiated Papillary Peritoneal Mesothelial Tumors.分化良好型腹膜间皮乳头状肿瘤患者的临床特征和转归。
Ann Surg Oncol. 2024 Nov;31(12):7973-7977. doi: 10.1245/s10434-024-16004-2. Epub 2024 Aug 21.
6
[Benign mesothelial tumors].[良性间皮瘤]
Pathologie (Heidelb). 2024 Sep;45(5):324-332. doi: 10.1007/s00292-024-01333-6. Epub 2024 May 2.
7
A case report of typical well-differentiated papillary mesothelial tumor diagnosed by internal thoracoscopy and literature review.经胸腔镜诊断的典型高分化乳头状间皮瘤病例报告及文献复习
Front Oncol. 2024 Apr 9;14:1359985. doi: 10.3389/fonc.2024.1359985. eCollection 2024.
8
Mesothelioma: morphologic and immunohistochemical findings.间皮瘤:形态学及免疫组化结果
Pathologie (Heidelb). 2024 Sep;45(5):309-315. doi: 10.1007/s00292-024-01317-6. Epub 2024 Apr 3.
9
Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies.恶性间皮瘤肿瘤:分子发病机制、诊断及伴随临床研究的治疗方法
Front Oncol. 2023 Jul 4;13:1204722. doi: 10.3389/fonc.2023.1204722. eCollection 2023.
10
Peritoneal papillary mesothelioma in situ: BAP1 mutation with indolent behavior for 15 years.腹膜原位乳头状间皮瘤:BAP1 突变,15 年来表现为惰性行为。
Virchows Arch. 2023 Dec;483(6):873-878. doi: 10.1007/s00428-023-03593-8. Epub 2023 Jul 10.